| Financial Year |
March 31 2023 |
| Monetary Funds |
323,413,543.17 |
| Held-for-trading Financial Assets |
170,428,219.18 |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
6,891,512.79 |
| Advances to Suppliers |
139,243,908.13 |
| Other Receivables |
4,542,011.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
196,583,910.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,776,966.44 |
| Total Current Assets |
862,880,071.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
333,319,162.77 |
| Under-construction Projects |
11,825,512.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
346,416,484.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
32,730,264.12 |
| Deferred Income Tax Assets |
1,221,641.31 |
| Other Non-Current Assets |
112,691,570.10 |
| Sub-Total of Non-Current Assets |
1,372,618,212.31 |
| Total Assets |
2,235,498,284.25 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
51,703,568.26 |
| Accounts Received In Advance |
13,801,122.20 |
| Employee Compensation Payable |
5,739,970.79 |
| Taxes Payable |
15,397,624.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,640,322.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,337,102.36 |
| Other Current Liabilities |
18,353,273.32 |
| Sub-Total of Current Liabilities |
278,152,009.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,577,700.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
261,610,490.83 |
| Total Liabilities |
539,762,500.78 |
| Paid-In Capital(Or Share Stock) |
173,394,000.00 |
| Capital Surplus |
843,541,973.33 |
| Surplus Reserve |
79,954,567.30 |
| LESS:Treasury Stock |
55,386,250.77 |
| Undistributed Profits |
649,306,752.86 |
| Minority Stockholder's Interest |
4,924,740.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,690,811,042.72 |
| Owner's Equity（Stockholder's Equity） |
1,695,735,783.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,235,498,284.25 |
